Clinical trial design articles within Cell Death & Disease

Featured

• Perspective
  12 May 2020 | Open Access

  Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment

  • Angela Flavia Serpico
  • , Roberta Visconti
  •  & Domenico Grieco

• News and Commentary
  19 November 2015 | Open Access

  Prospects of adjuvant RANKL inhibition in breast cancer?

  • T D Rachner
  • , P Wimberger
  •  & L C Hofbauer

• Original Article
  06 February 2014 | Open Access

  DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information

  • I Amelio
  • , M Gostev
  •  & A V Antonov